Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors

European Journal of Pharmacology

Volumn 358, Issue 1, 1998, Pages 9-18

  Hervás, Ildefonso ^a   Artigas, Francesc ^a  

^a INST D INVESTIGACIONS B   (Spain)

Author keywords

5 HT (5 hydroxytryptamine, serotonin) uptake; 5 HT(1A) receptor; Antidepressant; Dorsal raphe nucleus; Median raphe nucleus; Microdialysis

Indexed keywords

AUTORECEPTOR; FLUOXETINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN; SEROTONIN 1 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; FRONTAL CORTEX; HIPPOCAMPUS; MALE; MEDIAN RAPHE NUCLEUS; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; AUTORECEPTORS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EXTRACELLULAR SPACE; FLUOXETINE; FRONTAL LOBE; HIPPOCAMPUS; MALE; MICRODIALYSIS; PIPERAZINES; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0032566661     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00579-2     Document Type: Article

References (59)

1. Adell A., Artigas F. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo microdialysis study. Naunyn-Schmiedeberg's Arch. Pharmacol. 343:1991;237-244.
2. Artigas F. 5-HT and antidepressants: new views from microdialysis studies. Trends Pharmacol. Sci. 14:1993;262.
3. Artigas F., Pérez V., Álvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch. Gen. Psychiatry. 51:1994;248-251.
4. 1A antagonists. Trends Neurosci. 19:1996;378-383.
5. Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 179:1978;641-668.
6. Bel N., Artigas F. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur. J. Pharmacol. 229:1992;101-103.
7. Bel N., Artigas F. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse. 15:1993;243-245.
8. Blier P., Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J. Clin. Psychopharmacol. 15:1995;217-222.
9. 1 receptor agonists and p-chloroamphetamine. Synapse. 5:1990;120-133.
10. Bobillier P., Petitjean F., Salvert D., Ligier M., Seguin S. Differential projections of the nucleus raphe dorsalis and nucleus raphe centralis as revealed by autoradiography. Brain Res. 85:1975;205-210.
11. Bosker F.J., Klompmakers A.A., Westenberg H.G.M. Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology. 34:1995;501-508.
12. Caccia S., Cappi M., Fracasso C., Garattini S. Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology. 100:1990;509-514.
13. Casanovas J.M., Artigas F. Differential effects of ipsapirone on 5-HT release in the dorsal and median raphe neuronal pathways. J. Neurochem. 67:1996;1945-1952.
14. 1A agonists alnespirone (S-20499) and 8-OH-DPAT reduce extracellular 5-hydroxytryptamine in rat brain in a regionally-selective manner. Br. J. Pharmacol. 122:1997;733-741.
15. Dahlström A., Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system: I. Demonstration of monoamines in cell bodies of brain neurons. Acta Physiol. Scand. 62(Suppl. 232):1964;1-55.
16. Descarries L., Watkins K.C., Garcia S., Beaudet A. The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radioautographic study. J. Comp. Neurol. 207:1982;239-254.
17. 1A receptors. Neurochem. Res. 21:1996;557-562.
18. 1A receptor antagonist. Behav. Brain Res. 73:1995;337-353.
19. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115:1995;1064-1070.
20. 1B receptors with WAY 100,635 and GR 127,935. J. Neurochem. 68:1997;1159-1163.
21. Graeff F.G., Guimaraes F.S., Deandrade T.G.C.S., Deakin J.F.W. Role of 5-HT in stress, anxiety, and depression. Pharmacol. Biochem. Behav. 54:1996;129-141.
22. Hajos M., Gartside S.E., Sharp T. Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;624-629.
23. Hervás, I., Bel, N., Fernández, A.G., Palacios, J.M., Artigas, F., 1998. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei. Naunyn-Schmiedeberg's Arch. Pharmacol., in press.
24. 1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci. 48:1991;1779-1786.
25. 1A receptors or β-adrenoceptors, restrain the citalopram- induced increase in extracellular 5-hydroxytryptamine in vivo. Eur. J. Pharmacol. 316:1996;43-47.
26. 3H ] imipramine, localization and relationship to serotonin transporter J. Pharmacol. Exp. Ther. 252:1990;410-418.
27. 1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HT concentration and behaviour in the guinea pig. Neuropharmacology. 34:1995;383-392.
28. Imai H., Steindler D.A., Kitai S.T. The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J. Comp. Neurol. 243:1986;363-380.
29. Invernizzi R., Carli M., Di Clemente A., Samanin R. Administration of 8-hydroxy-2-(di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity. J. Neurochem. 56:1991;243-247.
30. Invernizzi R., Belli S., Samanin R. Citalopram's ability to increase the extracellular concentration of serotonin in the dorsal raphe prevents the drug's effect in frontal cortex. Brain Res. 584:1992;322-324.
31. 1A receptors. Eur. J. Pharmacol. 260:1994;243-246.
32. Invernizzi R., Bramante M., Samanin R. Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram. Brain Res. 696:1995;62-66.
33. 1A receptor antagonists on citalopram- induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus. Neuropharmacology. 36:1997;467-473.
34. Jacobs B.L., Wise W.D., Taylor K.M. Differential behavioral and neurochemical effects following lesions of the dorsal or median raphe nuclei in rats. Brain Res. 79:1974;353-361.
35. Köhler C., Steinbusch H. Identification of serotonin and non-serotonin containing neurons of the mid-brain raphe projecting to the entorhinal area and the hippocampal formation. A combined immunohistochemical and fluorescent retrograde tracing study in the rat brain. Neuroscience. 7:1982;951-975.
36. Kosofsky B.E., Molliver M.E. The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse. 1:1987;153-168.
37. Kreiss D.S., Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 274:1995;866-876.
38. Lorens S.A., Guldberg H.C. Regional 5-hydroxytryptamine following selective midbrain raphe lesions in the rat. Brain Res. 78:1974;45-56.
39. Malagié I., Trillat A.C., Jacquot C., Gardier A. Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study. Eur. J. Pharmacol. 286:1995;213-217.
40. Malagié I., Trillat A.C., Douvier E., Annella M.C., Dessalles M.C., Jacquot C., Gardier A.M. Regional diferences in the effect of combined treatment of WAY 100635 and fluoxetine. An in vivo microdialysis study. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:1996;785-790.
41. Mamounas L.A., Molliver M.E. Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA). Exp. Neurol. 102:1988;23-36.
42. McQuade R., Sharp T. Functional mapping of dorsal and median raphe 5-HT pathways in forebrain of the rat using microdialysis. J. Neurochem. 69:1997;791-796.
43. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
44. Pérez V., Gilaberte I., Faries D., Álvarez E., Artigas F. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet. 349:1997;1594-1597.
45. Perry K.W., Fuller R.W. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci. 50:1992;1683-1690.
46. 1A receptor antagonists in the dorsal raphe pathway. Role of somatodendritic autoreceptors. J. Neurochem. 68:1997;2593-2603.
47. 1A antagonist WAY 100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neurosci. Lett. 219:1996;123-126.
48. Rutter J.J., Auerbach S.B. Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol. Exp. Ther. 265:1993;1319-1324.
49. 1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Br. J. Pharmacol. 12:1997;941-946.
50. 1 receptor. Eur. J. Pharmacol. 157:1988;173-181.
51. 1D receptor antagonist. Behav. Brain Res. 73:1995;157-161.
52. 1D receptor antagonist GR127935 on extracellular levels of 5-HT in the guinea-pig frontal cortex as measured by microdialysis. Neuropharmacology. 34:1995;377-382.
53. Stanford S.C. Prozac: panacea or puzzle? Trends Pharmacol. Sci. 17:1996;150-154.
54. Starkey S.J., Skingle M. 5-HT(1D) as well as 5-HT(1A) autoreceptors modulate 5-HT release in the guinea-pig dorsal raphe nucleus. Neuropharmacology. 33:1994;393-402.
55. Steinbush, H.W.M., Nieuwenhuys, R., 1983. The raphe nuclei of the brainstem: a cytoarchitectonic and immunohistochemical study. In: Emson, P.C. (Ed.), Chemical Neuroanatomy. Raven Press, New York, NY, pp. 131-207.
56. Tomé M.R., Isaac M.T., Harte R., Holland C. Paroxetine and pindolol: a randomised trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. Int. Clin. Psychopharmacol. 12:1997;81-89.
57. Vertes R.P. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J. Comp. Neurol. 313:1991;643-668.
58. Wiklund L., Leger L., Persson M. Monoamine cell distribution in the cat brain stem. A fluorescence histochemical study with quantification of indoleaminergic and locus coeruleus cell groups. J. Comp. Neurol. 203:1981;613-647.
59. Zanardi R., Artigas F., Franchini L., Sforzini L., Gasperini M., Smeraldi E., Pérez J. How long pindolol should be associated to paroxetine to improve the antidepressant response? J. Clin. Psychopharmacol. 17:1997;446-450.